Incorporating NTCP into Randomized Trials of Proton Versus Photon Therapy [0.03%]
将正常组织并发症概率纳入质子治疗与光子治疗的随机试验中
Jonas Scherman,Ane L Appelt,Jen Yu et al.
Jonas Scherman et al.
Purpose: We propose and simulate a model-based methodology to incorporate heterogeneous treatment benefit of proton therapy (PrT) versus photon therapy into randomized trial designs. We use radiation-induced pneumonitis (...
IMPT versus VMAT for Pelvic Nodal Irradiation in Prostate Cancer: A Dosimetric Comparison [0.03%]
前列腺癌盆腔淋巴结照射中强度调制放疗与容积旋转调强放疗的剂量学对比研究
Thomas J Whitaker,David M Routman,Heather Schultz et al.
Thomas J Whitaker et al.
Purpose: To compare dosimetric data of the organs at risk (OARs) and clinical target volumes (CTVs) between intensity-modulated proton therapy (IMPT) and volumetric-modulated arc therapy (VMAT) for patients undergoing pro...
A Model for Secondary Monitor Unit Calculations of PBS Proton Therapy Treatment Plans [0.03%]
PBS质子治疗计划的次级剂量监测单位计算模型
Greg Schimke,Joseph Syh,Hsinshun Terry Wu
Greg Schimke
Purpose: This article summarizes a volume-based method by which secondary monitor unit (MU) calculations may be performed for pencil beam scanning, single field uniform dose (SFUD) proton therapy treatment plans. ...
Lillie O&#x;steen,Jason Bellardini,James Cury et al.
Lillie O&#x;steen et al.
Purpose: Acute and late toxicity from chemotherapy, targeted therapy, and radiation therapy can cause significant morbidity among survivors of Hodgkin lymphoma (HL), including pulmonary dysfunction. Improved dosimetry may...
[This corrects the article DOI: 10.14338/IJPT-15-00005.1.]. ©Copyright 2019 The Author(s).
[This corrects the article DOI: 10.14338/IJPT-16-00031.1.]. ©Copyright 2019 The Author(s).
[This corrects the article DOI: 10.14338/IJPT-16-00020.1.]. ©Copyright 2019 The Author(s).
Large Malignant Fibrous Histiocytoma Treated with Hypofractionated Proton Beam Therapy and Local Hyperthermia [0.03%]
超分割质子治疗和局部体热治疗恶性纤维组织细胞瘤一例报告
Takashi Iizumi,Shosei Shimizu,Haruko Numajiri et al.
Takashi Iizumi et al.
Purpose: Malignant fibrous histiocytoma (MFH) is one of the most common soft tissue sarcomas. The standard treatment is adequate surgical resection; in addition, radiation therapy plays a major role in perioperative treat...
Proton Therapy in the Treatment of Anal Cancer in Pelvic Kidney Transplant Recipients: A Case Series [0.03%]
前列腺治疗 pelvic kidney transplant recipients 分析报告
David Buchberger,Paul Kreinbrink,Jordan Kharofa
David Buchberger
Purpose: The incidence of anal cancer in patients with kidney transplants has increased. The definitive treatment for anal cancer is chemotherapy and intensity-modulated radiation therapy. In kidney transplant recipients,...